Evidence map›Paper›PMID 40632486›Full record

ArticleInternational journal of clinical pharmacy2026

Global, regional, and national burden of lip and oral cavity cancer and its attributable risk factors from 1990 to 2021: an analysis of the Global Burden of Disease study 2021.

Meiling Hu, Hui Chen, Ren Wang, Ruibin Zhang, Jun Yao, Xili Qiu, Jincai Guo

Abstract read
In one paragraph

Article in International journal of clinical pharmacy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Meiling Hu *Department of Pharmacy, Changsha Stomatological Hospital, Changsha, China.
Hui Chen *Department of Pharmacy, Changsha Stomatological Hospital, Changsha, China.
Ren WangDepartment of Pharmacy, Changsha Stomatological Hospital, Changsha, China.
Ruibin ZhangDepartment of Pharmacy, Changsha Stomatological Hospital, Changsha, China.
Jun YaoDepartment of Orthodontics, Changsha Stomatological Hospital, Changsha, China.
Xili QiuXiangya Stomatological Hospital and Xiangya School of Stomatology, Central South University, Changsha, China.
Jincai GuoDepartment of Pharmacy, Changsha Stomatological Hospital, Changsha, China. 540009728@qq.com.ORCID http://orcid.org/0000-0002-5472-0236

Funding

Chinese Medicine Research Project of Hunan Province No. B2023048Joint Fund of Universities and Colleges No. 2024XYLH290Natural Science Foundation of Changsha City No. kq2403178Natural Science Foundation of Hunan Province No. 2024JJ9532Scientific Research Project of the Hunan Health Commission No. D202313048136
6 · The paper itself

Abstract

backgroundLip and oral cavity cancer is a significant global health concern, with increasing incidence rates in recent years. Understanding epidemiological trends and their associated risk factors is crucial for effective prevention and management.

aimThis study aimed to analyze global, regional, and national trends in lip and oral cavity cancer incidence, mortality, and disability-adjusted life-years (DALYs) from 1990 to 2021 to assess key risk factors and sociodemographic influences to support clinical pharmacy interventions and improve patient outcomes.

methodLip and oral cavity cancer burden was analyzed by location, age, and sex. Joinpoint regression assessed trends, Spearman correlation measured sociodemographic index (SDI) associations, and decomposition analysis quantified population growth, aging, and epidemiological impacts. Cross-country disparities and risk factors were also evaluated.

resultsIn 2021, there were 421,577 (95% uncertainty interval [UI]: 389,879-449,782) new lip and oral cavity cancer cases, 208,379 (95% UI: 191,288-224,162) deaths, and 5,874,070 (95% UI: 5,326,986-6,347,557) DALYs globally, with the highest burden in South Asia. The age-standardized incidence rate (ASIR) increased significantly, while the age-standardized mortality rate (ASMR) and age-standardized DALYs rate slightly declined. Men and older adults had higher rates, but the increase was more pronounced in women and younger populations. ASIR correlated positively with SDI, while cross-country inequalities persisted, particularly in low-SDI regions. The contribution of tobacco chewing to lip and oral cavity cancer deaths and DALYs slightly increased.

conclusionThe incidence of lip and oral cavity cancer continues to increase, with a shifting burden on younger individuals and women. Targeted interventions to reduce risk factors and improve access to healthcare are essential for high-risk populations and regions.

Indexed as

Global Burden of DiseaseLip NeoplasmsMouth NeoplasmsAdultAgedCost of IllnessDisability-Adjusted Life YearsFemaleGlobal HealthHumansIncidenceMaleMiddle AgedRisk FactorsYoung AdultDisability-adjusted life yearsEpidemiologyGlobal Burden of DiseaseHealth inequalitiesIncidenceMortalityMouth neoplasmsRisk factors

Identifiers

PMID40632486
PMCPMC12823715

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.